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The myeloid cell-derived calcium-binding murine pro-
tein, S100A8, is secreted to act as a chemotactic factor at
picomolar concentrations, stimulating recruitment of
myeloid cells to inflammatory sites. S100A8 may be ex-
posed to oxygen metabolites, particularly hypochlorite,
the major oxidant generated by activated neutrophils at
inflammatory sites. Here we show that hypochlorite ox-
idizes the single Cys residue (Cys41) of S100A8. Electro-
spray mass spectrometry and SDS-polyacrylamide gel
electrophoresis analysis indicated that low concentra-
tions of hypochlorite (40 mM) converted 70–80% of
S100A8 to the disulfide-linked homodimer. The mass
was 20,707 Da, 92 Da more than expected, indicating
additional oxidation of susceptible amino acids (possi-
bly methionine). Phorbol 12-myristate 13-acetate activa-
tion of differentiated HL-60 granulocytic cells generated
an oxidative burst that was sufficient to efficiently oxi-
dize exogenous S100A8 within 10 min, and results impli-
cate involvement of the myeloperoxidase system. More-
over, disulfide-linked dimer was identified in lung
lavage fluid of mice with endotoxin-induced pulmonary
injury. S100A8 dimer was inactive in chemotaxis and
failed to recruit leukocytes in vivo. Positive chemotactic
activity of recombinant Ala41S100A8 indicated that
Cys41 was not essential for function and suggested that
covalent dimerization may structurally modify accessi-
bility of the chemotactic hinge domain. Disulfide-
dependent dimerization may be a physiologically sig-
nificant regulatory mechanism controlling S100A8-
provoked leukocyte recruitment.
Murine S100A8, also known as CP-10 (chemotactic protein,
10 kDa), myeloid-related protein 8, and calgranulin A (1), is a
small acidic protein containing two Ca21-binding EF hands
belonging to the highly conserved S100 protein family (2). Most
S100 proteins appear to function as intracellular calcium-mod-
ulated proteins that may regulate diverse functions including
cell growth, differentiation, energy metabolism, cytoskeletal-
membrane interactions, and kinase activities (1, 3). Extracel-
lular activities have been ascribed to at least five family mem-
bers, and since our description of the chemotactic activity of
S100A8, similar functions for S100A2 (S100L, chemotactic for
guinea pig eosinophils) and S100A7 (psoriasin, chemotactic for
human CD41 T lymphocytes and neutrophils) have been re-
ported (4, 5). S100B is an extracellular neurotrophic factor, and
mitogen (6) and human S100A8 and S100A9 are antimicrobial
and cytostatic (7) and have been associated with inflammatory
pathologies (reviewed in Ref. 8).
S100A8 is constitutively expressed with S100A9 in neutro-
phils. It is up-regulated by bacterial lipopolysaccharide (LPS)1
and interleukin 1 in macrophages (9) and microvascular endo-
thelial cells (10) and has been associated with neutrophil re-
cruitment in abscess formation (11) and bleomycin lung (12).
Our recent experiments also indicate an important role for
S100A8 in embryogenesis where it is expressed by migrating
trophoblasts, and deletion of the gene was lethal at mid-gesta-
tion.2 We recently demonstrated S100A8 secretion from LPS-
activated murine macrophages (9), and in the absence of a
secretion signal sequence, Rammes et al. (13) proposed a novel
tubulin-dependent pathway for S100A8/A9 release from acti-
vated human monocytes which may provide a paradigm for the
secretion of other S100 proteins.
S100A8 was isolated as a soluble product of activated murine
spleen cells (14) and in the picomolar range stimulates myeloid
cell chemotaxis in vitro (15) and a sustained leukocyte recruit-
ment, with mononuclear cell infiltration following an early
influx of neutrophils, in vivo (15, 16). Together with TGF-b, it
is one of the most potent chemotactic factors described. In
contrast to the classical chemoattractants such as fMet-Leu-
Phe, C5a, and the chemokines, S100A8 and TGF-b affect cy-
toskeletal actin polymerization and cell migration without
causing degranulation and activation (17).
ApoS100 proteins form antiparallel, noncovalently linked
dimers in solution (18, 19), and at physiological concentrations
in reducing environments, S100B would most likely exist as a
non-covalent homodimer (20). In contrast, the extracellular
neurotrophic and mitogenic activities of S100B are dependent
on redox status and inter- or intrachain disulfide bond forma-
tion (6, 21). Although there is no structural information, disul-
fide-mediated dimerization may also regulate some extracellu-
lar functions of other S100 proteins (19).
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Noncovalent heteromeric complexes of human S100A8 and
S100A9 (also known as myeloid-related protein 14 and calgranu-
lin B (1)) have been characterized (22) and are thought to repre-
sent the functional form, even though these proteins are not
always coordinately expressed (23). Our recent experiments con-
firm the propensity of murine S100A8 to form non-covalent
dimers in solution, and this property is independent of calcium
and covalent disulfide bond formation (24). Murine S100A8 com-
prises 88 amino acids with a single cysteine residue at position 41
(14). Here we show that the monomeric (non-covalent dimeric)
form of S100A8 was functional, whereas the oxidized homodimer
was chemotactically inactive. S100A8 was readily oxidized by
hypochlorite, a myeloperoxidase product generated by activated
neutrophils and macrophages and implicated in the pathogenesis
of inflammation and atherogenesis (25, 26). The efficiency by
which stimulated neutrophils oxidized exogenous S100A8 sug-
gests that the redox status of Cys41 of S100A8 may represent a
physiologically relevant regulatory mechanism controlling
S100A8-provoked leukocyte recruitment in vivo.
EXPERIMENTAL PROCEDURES
Materials
RPMI 1640 and fetal bovine serum were purchased from Life Tech-
nologies, Inc. Hanks’ balanced salt solution (HBSS), HBSS (without
CaCl2 and MgCl2), bovine serum albumin, sodium hypochlorite, di-
methyl sulfoxide (Me2SO), phorbol 12-myristate 13-acetate (PMA), N-
ethylmaleimide (NEM), and Triton X-100 were purchased from Sigma.
T4 DNA ligase, restriction enzymes, and Complete protease inhibitors
were obtained from Boehringer Mannheim (Mannheim, Germany), and
thioglycollate was from Difco.
S100A8 Analogues
Preparation and isolation of recombinant (r)S100A8 is described in
detail (27, 28). Synthetic S100A8 and the a-aminobutyric acid deriva-
tive (Aba41S100A8) will be described elsewhere.3 All S100A8 prepara-
tions were homogeneous by SDS-PAGE and ESI-MS analysis. Recom-
binant proteins differed from their synthetic and native counterparts by
an additional dipeptide, Gly-Ser, at the N terminus (27), and these
residues were designated as positions 22 and 21.
For Ala41S100A8 the oligonucleotide-directed mutagenesis was per-
formed using the double take double-stranded mutagenesis kit from
Stratagene (La Jolla, CA). Briefly, plasmid pS100A8-9 containing a
286-base pair BamHI fragment encoding the S100A8 cDNA (27) was
linearized at the unique ScaI restriction enzyme site in the ampicillin
resistance gene, biotinylated at the 39 ends with terminal deoxynucle-
otidyl transferase, purified from free biotinylated nucleotide using avi-
din-coated beads, and separated into single strands by alkali denatur-
ation. A ScaI extension primer complementary to the terminal 18 bases
of the 39 end of the template strand (59-ACTCACCAGTCACAGAAA-39)
and the Ala mutagenic primer complementary to the same strand and
containing base changes that alter codon specificity from Cys41 to Ala41
(59ACAAACTGAGGAGCCTCAGT AGTGAC-39) were annealed to the
captured template strand and extended with T7 DNA polymerase and
T4 DNA ligase. The strands were denatured using NaOH, and the
mutant strand was collected in the supernatant. A ScaI bridging primer
containing 18 bases complementary to the ScaI extension primer and 6
bases complementary to the first 6 bases on the other side of the ScaI
site (59-TTTCTGTGACTGGTGAGTACTCAA-39) was annealed to the
mutant strand thereby recircularizing the strand and extended with T7
DNA polymerase and T4 DNA ligase. The double-stranded closed cir-
cular molecules incorporating the mutation in both strands were trans-
formed into XL-1 Blue Escherichia coli (Stratagene). The sequence of
the mutated cDNA insert of one such recombinant, designated
pS100A8-9.1, was verified by the chain termination method of DNA
sequencing prior to subcloning into the BamHI site of the Glutagene
pGEX2T bacterial expression vector (AMRAD Pharmacia Biotech, Mel-
bourne, Australia) to produce the recombinant expression plasmid
pAla41S100A8.
High Performance Liquid Chromatography (HPLC)
All liquid chromatographic separations were performed using a non-
metallic LC 625 HPLC system and UV absorbance monitored at 214
and 280 nm with a Waters 490 UV/visible detector. Samples were
analyzed by C4 RP-HPLC using a Vydac 300 Å, 5 mm, 250 3 4.6 mm, C4
reverse phase column and gradient of 25–70% acetonitrile (0.1% triflu-
oroacetic acid) at 1 ml/min over 30 min. Fractions with major A214 nm
were collected manually.
Mass Spectrometry
Electrospray ionization (ESI)-mass spectra were acquired using a
single quadrupole mass spectrometer equipped with an electrospray
ionization source (Platform, VG-Fisons Instruments, Manchester, UK).
Samples (;50 pmol, 10 ml) were injected into a moving solvent (10
ml/min; 50:50 water:acetonitrile, 0.05% trifluoroacetic acid) using a
Phoenix 40 HPLC pump (VG-Fisons Instruments) coupled directly to
the ionization source via a fused silica capillary (50 mm 3 40 cm). The
source temperature was 50 °C, and nitrogen was used as the nebulizer
and drying gas. Sample droplets were ionized at a positive potential of
approximately 3 kV and transferred to the mass analyzer with a cone
voltage (sample cone to skimmer lens voltage) of 50 V. The peak width
at half-height was 1 Da. Spectra were acquired in multi-channel acqui-
sition mode over the mass range 700 to 1800 Da in 5 s and then
calibrated with horse heart myoglobin (Sigma). Some spectra were
recorded using a HP LC/MSD 1100 mass spectrometer (Hewlett-Pack-
ard, Palo Alto, CA) using similar conditions.
Oxidation of S100A8
Hypochlorite Oxidation—Recombinant S100A8, Ala41S100A8, S100A9,
hS100A8 (purified from human PMN)4 and bovine S100B (Sigma) were
used. Generally, 100 mg of S100 protein was reconstituted with 1 ml of
PBS, pH 7.5 (final concentration 1025 M). Hypochlorite, from a stock
solution of 45 mM (determined as described previously (40)) was diluted
in PBS, pH 7.5, to working solutions of 200 mM to 20 mM. S100 proteins
were treated with increasing concentrations of hypochlorite (10–100
mM) for 15 min on ice before an equal volume of 2 3 SDS-PAGE sample
mixture (6100 mM DTT) was added, and samples were heated (100 °C,
3 min) and analyzed by 10% SDS-PAGE and silver staining or Western
blotting using anti-S100A8. Alternatively, after 15 min, samples were
fractionated by RP-HPLC and the eluted peaks analyzed by mass
spectrometry.
Copper Oxidation—Recombinant S100A8 (100 ml of 1 mg/ml) purified
from C4 RP-HPLC (29) was reduced in volume by two-thirds (Speedvac;
Savant, Farmingdale, NY). An equal volume of ammonium bicarbonate
(0.1 M) was added prior to the addition of copper sulfate (50 mM) to a
final concentration of 2 mM. After 30 min at room temperature S100A8
homodimer was separated from residual monomer by C4 RP-HPLC.
PMA-induced Oxidation of S100A8 by Myeloid Cells—The human
promyelocytic cell line, HL-60, was differentiated to the granulocytic
lineage with Me2SO (1.25%) for 5 days as described (30). dHL-60 cells
were washed twice in HBSS or Ca21-free HBSS and resuspended (107
cells/ml) in the same solutions. Alternatively, murine PMN (107 cells/
ml) elicited 6 h after intraperitoneal injection of thioglycollate as de-
scribed (31) were used. Recombinant S100A8 (final concentration 1025
or 5 3 1027 M) was added to cell suspensions (106 cells) that were
subsequently activated with PMA (1 mg/ml) and incubated for 20 min at
37 °C. The rate of PMA-induced oxidation of S100A8 was measured by
incubating dHL-60 cells with PMA (1 mg/ml) for 1–30 min. After incu-
bation, an equal volume of 23 SDS-PAGE sample mixture was added,
and samples were analyzed by 10% non-reducing SDS-PAGE and silver
staining or Western blot analysis using anti-S100A8. In some experi-
ments sodium azide (10 nM to 100 mM) was included. All results shown
are representative of at least three experiments.
Induction of LPS-induced Pulmonary Injury
Male Quakenbush Swiss mice, aged 8 weeks, were from the Animal
Breeding and Holding Unit, University of New South Wales and exper-
imental procedures complied with the requirements of the University’s
Animal Care and Ethics Committee (reference number 96/124).
Lipopolysaccharide (LPS; Difco, E. coli 055:B5), 10 mg/60 ml, was
placed on the nares and introduced into the lung by inhalation accord-
ing to the method of Szarka et al. (52). Control mice received 60 ml of
PBS, pH 7.2. Each group comprised four mice. Animals were killed by
exsanguination after an overdose of pentobarbital at 48 h after intra-
nasal instillation. The lungs were perfused with 0.9% saline under a
pressure of 40 cm of H2O for 60 s to remove blood from the capillary bed.
The trachea was then cannulated with a blunted 19-gauge needle and
lungs lavaged. Bronchoalveolar lavage fluid was obtained by washing
3 P. Alewood, manuscript in preparation. 4 M. J. Raftery and C. L. Geczy, submitted for publication.
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the lungs three times repeatedly with 1 ml of PBS containing 10 mM
N-ethylmaleimide (NEM). NEM was included to prevent artifactual
formation of disulfide-linked S100A8 during isolation. Cells were pel-
leted (4 °C, 1200 rpm, 10 min), and in agreement with earlier studies
(52), this procedure yielded 150–250-fold increases in neutrophil num-
bers after 48 h. Supernatants were processed by SDS-PAGE and West-
ern blot analysis.
Chemotaxis Assay
S100A8 analogues (10 mg) lyophilized (Speedvac) with glycerol (5 ml)
were stored at 280 °C. Reconstitution was with 10 ml of 0.1% trifluoro-
acetic acid and 990 ml RPMI 1640 to give a 1026 M stock solution that
was serially diluted in RPMI 1640, 0.1% bovine serum albumin imme-
diately before use. The murine monocytoid cell line WEHI 265 was used
as responding cell (27), and chemotaxis was performed in a 48-well
microchemotaxis Boyden chamber (Neuro Probe Inc., Bethesda, MD) as
described (15). Endotoxin-activated mouse serum (EAMS, 5%) was used
as a positive control. Coomassie Blue/crystal violet was used to stain the
membranes and migrating cells quantitated (103 objective) using
planimetry measurements obtained from image analysis (Wild-Leitz,
Lane Cove, Australia). Data were analyzed using the Student’s t test (*
p , 0.01 versus controls).
Leukocyte Recruitment in Vivo
S100A8 analogues (30 mg) were reconstituted in 10 ml of 0.1% triflu-
oroacetic acid, neutralized to pH 6.5 with 0.1 M sodium phosphate, and
made to 1 ml with phenol red-free HBSS (PRF-HBSS) containing 0.1%
ovalbumin (53 crystalline, Calbiochem). S100A8 solutions were held
overnight at 4 °C and subsequently diluted with 2 ml of PRF-HBSS,
0.1% ovalbumin (S100A8 final concentration 1026 M). Specific patho-
gen-free female Balb/c mice (6–8 weeks) were injected intraperitoneally
with 1 ml of S100A8 (final concentration 10 mg per mouse), or ana-
logues, or vehicle control solution, sacrificed after 16 h (maximal leu-
kocyte recruitment occurred between 16 and 24 h (32)), and cells har-
vested by peritoneal lavage with 5 ml HBSS, 0.38% citrate, washed
twice, and counted.
RESULTS
Hypochlorite Oxidation of S100 Proteins—Hypochlorite
(OCl2) is a major oxidant produced by neutrophils in an in-
flammatory response (25), and the susceptibility of recombi-
nant murine S100A8 (10 mM) to oxidation by hypochlorite was
tested. Fig. 1A shows SDS-PAGE separation of rS100A8 sam-
ples treated with increasing concentrations of OCl2 (lanes
2–4). In contrast to the untreated monomeric form (lane 1),
which migrated with an apparent Mr of 10,000, as little as 10
mM OCl2 converted approximately 20% of the S100A8 monomer
to a higher molecular weight species (lane 2), and this in-
creased to 70–80% with 40 mM OCl2 (lane 3). The higher
molecular weight band (Mr 20,000) reacted with anti-S100A8
IgG in Western blot analysis and corresponded to disulfide-
bonded S100A8 dimer (data not shown). No obvious higher
molecular weight complexes were evident in any of the samples
(lanes 2–4). At higher OCl2 concentrations (100 mM, lane 4)
there was an apparent loss of protein detected by silver stain-
ing. Hypochlorite-induced dimerization of S100A8 occurred
consistently in 10 separate experiments. Reduction of OCl2-
oxidized samples with 100 mM DTT prior to electrophoresis
resolved mainly components of Mr 10,000 (Fig. 1A, lanes 6–8)
with a minor amount of the 20-kDa species remaining in the
sample treated with the highest concentration of OCl2 (lane 8),
indicating the formation of a disulfide bond in the OCl2-in-
duced S100A8 dimer. The resistance of Ala41S100A8 (a mu-
tated form in which Ala41 was substituted for Cys41) to OCl2-
mediated dimerization (Fig. 1B, lanes 1–4), even at high OCl2
concentrations (100 mM, lane 4), confirmed the formation of
disulfide-linked dimers in the native form. The native human
S100A8 responded to OCl2 in a similar manner (Fig. 1B, lanes
5–8). Higher molecular weight components were apparent in
oxidized (Fig. 1B, lanes 6–8) and non-oxidized (Fig. 1B, lane 5)
samples, and these represent minor contaminants in the native
preparation as levels did not change with OCl2 treatment.
Murine S100A9 forms a non-covalent heterodimer with
S100A8 (34) and contains a free Cys residue at position 110
(29). In contrast to S100A8, OCl2 treatment of murine S100A9
failed to form covalent dimers of the expected mass (;28 kDa).
Instead, stepwise increases in apparent molecular weight were
evident with increasing concentrations of OCl2 (up to ;1 kDa
at 40 mM and ;2 kDa at 250 mM, Fig. 2A). Silver staining
indicated no apparent loss of S100A9 when OCl2 concentra-
tions .100 mM were used (Fig. 2A, lane 5).
When low amounts of OCl2 were added to equimolar mix-
tures of S100A8 and S100A9 (Fig. 2B) only low levels (,5%) of
the disulfide-linked heterodimer (24 kDa) were formed. Silver
staining indicated that S100A8 was predominantly oxidized to
the 20-kDa homodimer and oxidation was almost complete
with 40 mM OCl2. In contrast, S100A9 was principally con-
verted to a higher molecular weight (;16 kDa), monomeric
form (see Fig. 2A, lane 5). Western blot analysis with anti-
S100A8 confirmed preferential formation of disulfide-linked
S100A8 homodimer after oxidation with OCl2 (Fig. 2C). Anti-
S100A8 also reacted with the heterodimer even though this
represented ,5% of the reaction product (Fig. 2B). Anti-
S100A9 recognized the oxidized monomeric forms of S100A9
(Fig. 2D, lanes 2–4) and reacted well with the low levels of
heterodimer (24 kDa) and homodimer (28 kDa) generated after
oxidation with OCl2.
Characterization of OCl2-oxidized S100A8—The concentra-
tion of OCl2 required to convert murine S100A8 monomer
(retention time 19.2 min by C4 RP-HPLC) to predominantly
dimer was specific. With 10 mM S100A8 and 10 mM OCl2 in the
assay, a small amount of product with a retention time of 19.8
min was evident by HPLC analysis (Fig. 3A). SDS-PAGE anal-
ysis indicated that this species had an apparent Mr of 20,000
and reacted with anti-S100A8 IgG by Western blotting (not
shown). Approximately 70–80% of S100A8 was converted to
the higher molecular weight form by 40 mM OCl2 (Fig. 3B).
Small amounts of apparently monomeric S100A8 (19.2 min)
and other reaction products (18.4–19.0 min) were evident.
Higher concentrations of OCl2 (100 mM) produced multiple
oxidation species (Fig. 3C), and total protein recovery was
FIG. 1. Hypochlorite oxidizes S100A8 to the covalent dimer. A,
recombinant murine S100A8 (10 mM) was either untreated (lanes 1 and
5) or treated with increasing concentrations of hypochlorite. Proteins
were separated on SDS-PAGE in the absence (lanes 1–4) or presence
(lanes 5–8) of 100 mM DTT prior to silver staining. B, Ala41S100A8 (10
mM, lanes 1–4) or human S100A8 (10 mM, lanes 5–8) were treated
identically to murine S100A8 and proteins separated on SDS-PAGE in
the absence of reducing agents. Relative positions of molecular mass
markers, in kDa, are shown in both gels.
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reduced by ;75%.
Table I compares the masses determined by ESI-MS of
rS100A8 derivatives isolated after OCl2 (40 mM) treatment
with those determined previously for S100A8 monomer (29).
Hypochlorite oxidation generated both modified monomeric
and dimeric species. The monomeric form (retention time 19.2
min., Fig. 3B) had an additional 46 Da associated with it, and
the addition of three oxygens (mass 48 Da) may account for this
increased mass. The main oxidation product (retention time
19.8 min, Fig. 3B) had a mass of 20,707 Da confirming that, at
40 mM OCl2, disulfide bond formation was the most likely
outcome. The additional 92 Da associated with this product
presumably represents the dimeric form of the modified mon-
omer. Characterization of these modifications are in progress.
A major aim of this study was to assess the activity of the
murine S100A8 dimer in vivo and in vitro. Although OCl2
oxidation of S100A8 generated a dimeric species, RP-HPLC
profiles and mass spectrometry data suggested that formation
of a disulfide bond was not the only modification. Screening of
other potential agents indicated that Cu21 oxidized S100A8
more efficiently than OCl2 and produced a more homogeneous
product. Fig. 4 shows that Cu21 converted approximately 85%
of S100A8 monomer to a single oxidative product with reten-
tion time of 19.80 min and mass of 20,615 6 2 Da (inset). The
mass was identical to the predicted mass (20,615 Da) of the
disulfide-linked form, and reduction with DTT totally con-
verted the dimer to monomer of mass 10,308 Da.
PMA-activated HL-60 Granulocytic Cells Oxidize S100A8—
To determine whether murine S100A8 could be oxidized as a
FIG. 2. Murine S100A9 fails to form disulfide-linked ho-
modimers following hypochlorite oxidation. A, S100A9 (10 mM)
was either untreated (lane 1) or treated with increasing concentrations
of hypochlorite. Proteins were separated on SDS-PAGE in the absence
of reducing agents prior to silver staining. B, equal concentrations of
S100A8 and S100A9 (5 mM) were mixed and either untreated (lane 1) or
treated with increasing concentrations of hypochlorite. Proteins were
separated on SDS-PAGE in the absence of DTT. Molecular weight
markers for both gels are shown. To better identify the molecular
species in B, Western blot analyses using anti-S100A8 (C) and anti-
S100A9 (D) antibodies were performed.
FIG. 3. Comparison of C4 RP-HPLC elution profiles of S100A8
oxidized by hypochlorite. rS100A8 (10 mM) was oxidized with 10 mM
(A), 40 mM (B), and 100 mM (C) hypochlorite for 15 min and fractionated
by C4 RP-HPLC. The elution profile of untreated rS100A8 from C4
RP-HPLC is shown by the dashed line.
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consequence of neutrophil activation, differentiated (d)HL-60
granulocytic cells were activated with PMA using defined con-
ditions that generate an oxidative burst by these cells (30).
Generation of oxygen metabolites was confirmed by reduction
of nitro blue tetrazolium in our experiments. Fig. 5A shows a
time course of PMA-induced dHL-60 oxidation of exogenous
S100A8 (10 mM). Unstimulated cells (lane 1) did not convert
S100A8 to dimer over 30 min, whereas PMA (1 mg/ml) triggered
the rapid oxidation of monomer to dimer, evident after 1 min
(lane 2) and with 95% conversion within 10 min (lane 6). Using
this concentration of PMA, no loss of S100A8 was evident
during the time course. It is noteworthy that no additional
major oxidation products were evident under these experi-
mental conditions and that cell-induced dimers were reduced
by DTT. Thioglycollate-elicited murine PMN oxidized
S100A8 in the same manner in response to PMA activation
(not shown).
Similarly, levels of S100A8 identified in inflammatory con-
ditions such as rheumatoid plasma (;600 nM) (53) and cystic
fibrosis plasma (;200 nM) (54), when added to PMA-activated
dHL-60 cells, were also oxidized to the disulfide-linked ho-
modimer. Western blot analysis shows that monomer (Fig. 5B,
lane 1) to dimer (lane 6) conversion of 500 nM S100A8 occurred
30 min after neutrophil activation. Anti-S100A8 reacted some-
what more strongly with the homodimer than the monomer.
The susceptibility of S100A8 to OCl2-induced oxidation sug-
gested the involvement of the myeloperoxidase-H2O2-halide
system in the cellular oxidation of S100A8. This was supported
by the inhibitory effects of the myeloperoxidase inhibitor so-
dium azide on S100A8 oxidation. Fig. 5C shows that PMA-
activated dHL-60 cells, in the absence of sodium azide, con-
verted all S100A8 to the dimer in 30 min (lane 2). At low azide
concentrations (10–100 nM, lanes 3 and 4) no inhibition oc-
curred, whereas higher concentrations reduced dimer forma-
tion (1–10 mM, lanes 5 and 6), and oxidation was abolished at
azide concentrations exceeding 100 mM (lanes 7 and 8).
S100A8 Homodimer Formation at the Site of LPS-induced
Pulmonary Injury—Bronchoalveolar lavage fluid obtained
from mice after LPS inhalation contained significantly more
neutrophils than from PBS-treated controls. Protein levels in
the extracellular fluid were higher (Fig. 6, lane 2) in the treated
group and components migrating at 10 and 20 kDa (arrows)
were increased. Western blot analysis (Fig. 6, lane 4) confirmed
S100A8 monomer and homodimer in LPS-induced fluid. No
S100A8/A9 covalent complex was observed. A 70-kDa protein
also reacted with anti-S100A8 and may represent a high mo-
lecular weight complex of S100A8. This component and the
dimer were reduced by DTT (Fig. 6, lane 5) indicating disulfide
bond formation.
Chemotactic Activity of S100A8 and Analogues—S100A8 and
analogues were tested for their chemotactic activity in vitro.
Fig. 7 shows that WEHI monocytoid cells had little spontane-
ous migration (45 6 24 cells/field) but responded to increasing
dilutions of rS100A8 in a characteristic bell-shaped profile (27),
with optimal activity at 10211 M (226 6 32 cells/field). The
recombinant mutant, Ala41S100A8, was also active with a dose
response similar to that of the unmodified recombinant protein
(200 6 34 cells/field) although potency at higher (.10210 M)
and lower (,10212 M) concentrations was consistently less than
that of the unmodified form. Checkerboard analysis, performed
as described (15), confirmed chemotactic rather than chemoki-
netic activity for Ala41S100A8. Table II compares the chemo-
tactic activity of all available murine S100A8 analogues at
their optimal chemotactic concentrations.
Native S100A8, synthetic, and Aba41S100A8 all had optimal
activities of 10212 M and were of similar potencies.
Aba41S100A8 recruited somewhat greater numbers of cells,
although differences between the preparations were not statis-
tically significant. Furthermore, potencies of these analogues
were similar to the positive control, 5% EAMS (contains C5a).
In agreement with our earlier report demonstrating the che-
motactic potential of rS100A8 (27), the optimal activities of
rS100A8 and Ala41S100A8 were some 10-fold less (10211 M)
than the native and synthetic forms, but similar numbers of
cells were recruited. In marked contrast, Cu21-oxidized
S100A8 homodimer recruited 66 6 20 cells when tested at
10211 and 72 6 31 with 10212 M, and although these values
were consistently higher, recruitment was not significantly
different (p , 0.5) from control values (45 6 24 cells/field). No
migration above control values was evident at other concentra-
tions tested (Fig. 7). The OCl2-oxidized dimeric form of S100A8
also failed to recruit WEHI cells (not shown).
Leukocyte Recruitment in Vivo—Table III shows that intra-
peritoneal injection of the monomeric forms of S100A8, includ-
ing the Cys to Ala/Aba mutants, stimulated leukocyte recruit-
ment after 16 h. As described earlier for S100A842–55 (15),
infiltrates consisted of mixtures of neutrophils and monocytes
at this time. Although responses were variable between differ-
ent batches of mice, they were greater than controls (p , 0.01),
and no differences were obvious between preparations. In con-
trast, little leukocyte infiltration occurred in the buffer-injected
controls (1.2 6 0.5 3 106 cells) or in mice injected with disul-
fide-linked dimer (1.5 6 0.8 3 106 cells) prepared by Cu21
oxidation. Dose-response curves indicated that 5–10 mg of the
TABLE I
ESI mass spectrometry of hypochlorite-treated rS100A8 derivatives
Untreated rS100A8 (10 mM) or that treated with 40 mM OCl2 (see Fig.
3B) were subjected to mass spectrometry as described. ND, not deter-
mined.
Sample HPLC retention time ESI mass Provisionalassignment
min Da
rS100A8 19.3 10,307.5
OCl2
oxidation
18.7 ND
19.2 10,353 Modified rS100A8
with additional
46 Da
19.8 20,707 Disulfide-linked
dimer of modified
rS100A8 (192)
FIG. 4. S100A8 is susceptible to copper oxidation. Elution pro-
file of rS100A8 (20 mg) from C4 RP-HPLC (dashed line) and after
treatment with 2 mM CuSO4 for 30 min is shown. S100A8 homodimer,
elution time 19.8 min (solid line), was separated from residual monomer
by RP-HPLC. Inset, ESI mass spectrum of copper-oxidized S100A8
homodimer.
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S100A8 analogues (5 3 1027-1026 M) provoked optimal
responses.
DISCUSSION
Intracellular S100 proteins exist mainly as non-covalent ho-
mo- or heterodimers with free reduced sulfhydryl groups. How-
ever, the demonstration that disulfide formation (whether in-
ter- or intrachain) is required for the extracellular neurotrophic
and mitogenic activities of S100B (6, 21) suggests that S100
proteins contain specific amino acids that are prone to oxida-
tion, and that this reaction may selectively regulate bioactivity
(35). In view of the sensitivity of cysteine residues to oxidation,
and of their potentially important functional role in defining
target protein-binding sites in S100 proteins (36, 37), our strat-
egy was to determine whether oxidation of the single Cys
residue at position 41 modified murine S100A8 function.
PMNs secrete granular enzymes and oxygen metabolites
following exposure to activating agents such as PMA and to
classical chemoattractants (38). The two-electron (non-radical)
oxidant hypochlorite is a major product of stimulated neutro-
phils that produce superoxide radicals which dismute to H2O2
and are then converted into hypohalous acids by myeloperoxi-
FIG. 5. PMA-induced dHL-60 cellu-
lar oxidation of rS100A8. A, time
course of PMA-induced dHL-60 oxidation
of S100A8. S100A8 (10 mM) was added to
unstimulated (lane 1) or PMA-stimulated
(1 mg/ml, lanes 2–9) dHL-60 cells, and the
reaction was allowed to proceed for vari-
ous times. Proteins were separated on
SDS-PAGE in the absence of reducing
agent and silver stained. B, at more phys-
iological concentrations of S100A8, West-
ern blot analysis was required to visualize
protein. S100A8 (500 nM) was added to
unstimulated (lane 1) or PMA-stimulated
(1 mg/ml, lanes 2–6) dHL-60 cells, and
samples were analyzed as described
above. C, S100A8 (10 mM) was added to
unstimulated (lane 1) or PMA-stimulated
(1 mg/ml PMA, lanes 2–8) dHL-60 cells for
30 min at 37 °C in the absence (lane 2) or
presence of increasing sodium azide con-
centrations. Following incubation sam-
ples were analyzed by 10% SDS-PAGE
and silver staining. Relative positions of
molecular weight markers are shown.
FIG. 6. S100A8 dimer formation at the site of LPS-induced
pulmonary injury. Total protein present in BAL fluid of PBS control
animals (lane 1) was compared with BAL fluid from LPS-treated ani-
mals (lane 2) by silver staining. The positions of 10- and 20-kDa pro-
teins up-regulated in response to LPS are indicated (arrows). The same
samples were analyzed by Western blotting using anti-S100A8 (PBS
control, lane 3; LPS-treated, lane 4). The LPS-treated lung lavage
sample was also reduced with 100 mM DTT (lane 5). The relative
positions of molecular weight markers are shown.
FIG. 7. The covalent S100A8 homodimer is not chemotactic.
The chemotactic response of WEHI 265 cells toward rS100A8 (l),
Ala41S100A8 (E), and S100A8 homodimer (3). Migration in the absence
of a chemotactic stimulus is given (solid line). Data represent the
mean 6 S.E. of results obtained from three separate experiments in
which four to five grid fields of triplicate determinations were
quantitated.
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dase in the presence of halides (25). Hypochlorite-modified
proteins are implicated in inflammatory processes. For exam-
ple, human a1-proteinase inhibitor contains a critical methio-
nine (position 358) in its reactive center, which is susceptible to
OCl2 oxidation (39), rendering it an ineffective inhibitor of
neutrophil elastase (39). Hypochlorite-oxidized proteins have
also been identified in human atherosclerotic lesions (26), and
OCl2 can transform lipoprotein into a high uptake form
without significant lipid oxidation. ApoB-100, the single ma-
jor protein associated with low density lipoprotein, is the main
target for this oxidant (40) which becomes aggregated and
cross-linked.
S100A8 and S100A9 are constitutive cytoplasmic proteins in
neutrophils and are released in high concentrations at inflam-
matory sites (11, 12, 41) making them potential candidates for
OCl2-mediated oxidation. Indeed, S100A8 oxidation to the di-
sulfide-linked dimer increased from 20% in the presence of 10
mM hypochlorite to 70–80% with 40 mM hypochlorite (Fig. 1A).
The physiological significance of this mechanism is highlighted
by the observation that activated neutrophils (106) can gener-
ate as much as 124 mM hypochlorite within 2 h of stimulation
(42). Covalent disulfide bond formation in response to OCl2
was confirmed by mass spectral analysis (Table I), by reduction
of dimer to monomer with 100 mM DTT (Fig. 1A), and by the
failure of Ala41S100A8 to dimerize, even at high concentrations
of oxidant (Fig. 1B). In keeping with its high structural simi-
larity to the murine protein (14), the response of human
S100A8 to OCl2 was similar (1B). Cys42 of human S100A8 and
Cys41 of murine S100A8 are in the a-helix immediately preced-
ing the hinge region (a 13-amino acid domain separating the
two calcium-binding EF hand domains), and similar responses
were not unexpected. Nitric oxide, another important product
of activated myeloid cells, reacts readily with free radicals such
as superoxide anion (O2
.) to form peroxynitrite (ONOO2), and
NO and its oxidation products can modify thiols to yield bio-
logically active reaction products (33). The NO donor SIN-1 and
peroxynitrite anion oxidized S100A8 to the disulfide-linked
dimer, but neither was as effective as OCl2 (not shown).
In contrast to S100A8, OCl2 failed to convert murine S100A9
into disulfide-linked homodimers (Fig. 2A) although it de-
creased its apparent electrophoretic mobility, possibly by oxi-
dizing susceptible amino acids, including the Cys at position
110 and the 7 Met residues, resulting in changes in conforma-
tion or net charge. The propensity for S100A8 and S100A9 to
form disulfide-linked dimers in solution has not been charac-
terized. To examine this, equimolar mixtures of the proteins
were treated with OCl2, but no significant amounts of covalent
heterodimer were detected (Fig. 2B). In support of these find-
ings, a model of the putative human S100A8-S100A9 complex
by Hunter and Chazin (43) predicted that the distance between
Cys42 in S100A8 and Cys3 in S100A9 would make disulfide
bond formation in the heterodimer highly unlikely. Our results
indicate that although the free Cys (Cys110) of murine S100A9
occurs in the extended C-terminal domain, disulfide het-
erodimerization was similarly unlikely (Fig. 2B).
Relative peak areas (RP-HPLC) after oxidation with hypo-
chlorite (40 mM; Fig. 3B) showed approximately 75% conversion
of S100A8 monomer to homodimer. Mass spectrometry indi-
cated a mass of 20,707 6 2 Da (Table I), some 92 Da greater
than the Cu21-oxidized dimer. Thus, even at OCl2 concentra-
tions lower than those likely to occur in an inflammatory re-
sponse, modifications of amino acids, in addition to that at
Cys41, are indicated. These probably include incorporation of
oxygen atoms at Met36 and Met73. Interestingly, the potent
chemoattractants, fMet-Leu-Phe and human C5a are inacti-
vated by the myeloperoxidase-halide system by conversion of
methionine to the sulfoxide (44). The ability of stimulated
neutrophils to chemically modify chemoattractants may be one
means of limiting excess accumulation of leukocytes and ter-
minating the progression of acute inflammation. We are cur-
rently investigating whether specific oxidation of Met residues
in S100A8 affect chemotactic activity.
At higher OCl2 concentrations (.100 mM), oxidation of
S100A8 was less specific. C4 RP-HPLC indicated a heteroge-
neous assortment of products (Fig. 3C), and SDS-PAGE anal-
ysis confirmed multiple monomeric and dimeric species sug-
gesting a variety of modifications of susceptible amino acids.
Moreover, the large reduction in recovered protein (;75%)
suggested that precipitation and/or aggregation had occurred
(Figs. 1A and 3C). Similarly, OCl2 aggregates and cross-links
low density lipoprotein (40) and H2O2 oxidation of albumin at
molar ratios .30:1 causes precipitation, presumably due to the
formation of polymeric albumin derivatives, and precipitation
is proportional to the amount of peroxide added (46).
The physiological relevance of oxidation of murine S100A8
by OCl2 was highlighted by the ability of PMA-activated neu-
trophils to totally convert exogenous S100A8 to the covalent
dimer (Fig. 5A). The myeloperoxidase inhibitor sodium azide
totally inhibited the cell-mediated oxidation of S100A8 (Fig.
5B). With the presumption that sodium azide is solely an in-
hibitor of myeloperoxidase, we conclude from these data that
myeloperoxidase products are responsible for the majority of
cell-mediated S100A8 oxidation (47). Oxidation by 106 acti-
vated dHL-60 cells was rapid, with approximately 90% conver-
TABLE II
Chemotactic responses provoked by S100A8 and analogues
The chemotactic potential of S100A8 and analogues were tested in
chemotaxis assays using WEHI 265 as indicator cells. Data represent
the mean 6 S.E. of results obtained from three separate experiments in
which cells migrated in five grid fields in triplicate determinations were
quantitated. BSA, bovine serum albumin.
Chemoattractant Cells/field
Control, RPMI 1640, 0.1% BSA 45 6 24
nS100A8 (10212M)a 215 6 52b
sS100A8 (10212M) 192 6 53b
Aba41S100A8 (10
212M) 273 6 84b
rS100A8 (10211M) 226 6 32b
Ala41S100A8 (10
211M) 200 6 34b
S100A8 homodimer (10212M) 72 6 31
5% EAMSc 235 6 77b
a The abbreviations used are: N, native; s, synthetic; Aba, a-aminobu-
tyric acid; r, recombinant; Ala, recombinant mutant. The S100A8 ho-
modimer was the covalent form prepared by copper oxidation and
purified as shown in Fig. 4.
b p , 0.01 compared with controls.
c 5% endotoxin-activated mouse serum (EAMS) was used as positive
control in all experiments.
TABLE III
Leukocyte recruitment in response to S100A8 analogues in vivo
S100A8 analogues (10 mg in 1 ml of HBSS, 0.1% ovalbumin) or
diluent (control) were injected intraperitoneally into Balb/c mice as
described under “Experimental Procedures.” The leukocyte infiltrate
was harvested by peritoneal lavage 16 h later, and total cells were
quantitated. Data represent the mean 6 S.E. of results obtained from
four or five experiments in which a minimum of three mice/experiment
were injected.
Chemoattractant Cells recruited (3106)
Diluent control 1.2 6 0.5
nS100A8 7.9 6 4.5a
sS100A8 6.8 6 1.4a
Aba41S100A8 8.0 6 5.0
a
rS100A8 9.7 6 4.7a
Ala43S100A8 8.1 6 3.4
a
S100A8 homodimer 1.5 6 0.8
a p , 0.01 compared to diluent control values.
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sion of 1 mg of S100A8 to the dimer within 10 min (Fig. 4A).
Similar results were obtained with elicited murine neutrophils
activated in the same manner. No loss/aggregation of S100A8
was evident during the cellular activation process. Further-
more, disulfide-linked homodimer, but not heterodimer, was
detected in bronchoalveolar lavage fluid of endotoxin-treated
mice, confirming the limited heterodimer conversion observed
in Fig. 2. A higher molecular weight form, possibly correspond-
ing to components formed by aggregation (see Fig. 3), was also
detected.
In marked contrast to the potent chemotactic activity of
recombinant, synthetic, and native S100A8, disulfide-linked
S100A8 homodimer was inactive in vitro (Fig. 7 and Table II).
Moreover, these S100A8 preparations recruited between 4.8-
(sS100A8) and 6.5-fold (rS100A8) more leukocytes than the
disulfide-linked dimer following intraperitoneal injection (Ta-
ble III), suggesting that availability of unmodified Cys41 might
be functionally important. Site-directed mutagenesis studies of
S100B indicated that Cys68 and Cys84 were essential for extra-
cellular neurotrophic and mitogenic activities (52). However,
the Cys mutant forms of S100A8, recombinant Ala41S100A8
and synthetic Aba41S100A8, recruited similar numbers of leu-
kocytes to their unmodified recombinant or synthetic counter-
parts in vitro and in vivo (Table III and Fig. 7) indicating that
Cys41 was not essential for recruitment. This extends our ear-
lier studies demonstrating chemotactic activity of the hinge
region peptide of S100A8 (S100A842–55), although the potency
of the peptide was somewhat less than the full-length form (14).
These experiments indicate alternate mechanisms for inacti-
vation of S100A8 bioactivity whereby disulfide interactions
involving Cys41 may sterically hinder and/or structurally alter
exposure of the chemotactic hinge domain to restrict cellular
target recognition.
Inactivation of the chemotactic activity of S100A8 by hypo-
chlorite oxidation may provide a mechanism for limiting excess
accumulation of leukocytes and terminating the progression of
acute inflammation. Recruitment of neutrophils from the vas-
cular lumen into the pulmonary airspace of LPS-treated mice
begins within hours of intranasal instillation, and these cells
accumulate in the airways within 24–48 h (52). Although time
course experiments are warranted, Fig. 6 indicates that
S100A8 was oxidized to the homodimer and higher aggregates
in vivo at the time that the inflammatory response entered the
resolution phase.
The efficiency of OCl2 oxidation of S100A8 may have addi-
tional implications. Approximately 20% of cytoplasmic protein
of neutrophils is S100A8 (48), and necrotic neutrophils have
the potential to release large amounts following an inflamma-
tory stimulus (11, 12, 41). Activated monocytes (13) and macro-
phages (9) also release the protein. Even in the presence of
equimolar amounts of S100A9, high concentrations of S100A8
may be a preferential target of oxygen metabolites (OCl2, NO),
thereby protecting other tissue proteins from excessive oxida-
tive damage. This may represent an important function of
human S100A8 which, unlike the murine protein, is not che-
motactic (15). Murine S100A8 may therefore have pro- or anti-
inflammatory activity, depending on its extracellular concen-
tration and circumstance of release. This may be particularly
relevant at sites of Gram-negative infection. In support of an
anti-inflammatory role, recent experiments in our laboratory5
have demonstrated glucocorticoid-mediated up-regulation of
S100A8 mRNA and protein in macrophages stimulated with
LPS. Glucocorticoids released via the neuroendocrine-immune
network during stress have an immunomodulatory function
during infection and tissue invasion (49). The apparently op-
posing activities of promoting and modulating inflammation
are not unique to S100A8. Transforming growth factor b1
(TGF-b) is implicated in embryogenesis, development, and im-
mune and inflammatory processes and shares this paradoxical
behavior (50). S100A8 is also implicated in embryogenesis and
development (51), and TGF-b is also chemotactic for myeloid
cells at picomolar concentrations (17). The studies presented
here provide a novel mechanism of regulation of the chemotac-
tic activity of S100A8 by the myeloperoxidase system in neu-
trophils and suggest that release of this abundant protein by
dying neutrophils at acute inflammatory sites may have a
protective role.
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